Seeking Alpha

  Repligen Corporation (RGEN) - NASDAQ

  • timtrading | Send Message 25 Apr 2012

    bought $RGEN at 6.52, stop loss 6.47 -
      RGEN vs. ETF Alternatives
      Company Description
      Repligen Corp is a life sciences company engaged in the development, manufacture & sale of consumable bioprocessing products for life sciences companies & biopharmaceutical manufacturing companies. It also supplies growth factor products.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States